Oruka Therapeutics, Inc. (ORKA)

CIK 907654 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oruka Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 1, 20261440001950047-26-008949
Sep 1, 202640000907654-26-000087
Sep 1, 20261440001950047-26-008954
Sep 1, 202640000907654-26-000088
Aug 28, 2026424B50001213900-26-095041
Aug 27, 2026EFFECT9999999995-26-002787
Aug 25, 202640000907654-26-000084
Aug 25, 202630000907654-26-000083
Aug 24, 20268-K0001213900-26-093021
Aug 21, 2026S-30001213900-26-092612
Aug 17, 202640000907654-26-000079
Aug 14, 202640000907654-26-000075
Aug 14, 202640000907654-26-000077
Aug 14, 2026SCHEDULE 13G/A0000905148-26-003735
Aug 14, 2026SCHEDULE 13G0001493215-26-000153
Aug 14, 20261440001950047-26-008164
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000934
Aug 12, 2026SCHEDULE 13G0001422849-26-000148
Aug 10, 202610-Q0001213900-26-087231
Aug 10, 20268-K0001213900-26-086933
Jul 15, 202640000907654-26-000073
Jul 15, 20261440001950047-26-007123
Jul 13, 202640000907654-26-000071
Jul 13, 20261440001950047-26-007037
Jul 1, 20261440001104659-26-080011